The Use of mRNA for an HIV Envelope Vaccine (R43/R44)

0
242
Funding Opportunity Number: PA-16-207
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
CFDA Number: 93.855
93.856
Eligible Applicants Small businesses
Agency Name: HHS-NIH11
Closing Date: Apr 05, 2019
Award Ceiling:
Expected Number of Awards:
Creation Date: Apr 19, 2016
Funding Opportunity Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Innovation Research (SBIR) grant applications from Small Business Concerns (SBCs) that will focus on the development of novel direct mRNA-based and self-amplifying mRNA-based HIV envelope vaccine platforms suitable for use in clinical research. Such technologies should have commercial potential.

Source:: http://www.grants.gov/web/grants/view-opportunity.html?oppId=283150

LEAVE A REPLY

Please enter your comment!
Please enter your name here